Outcome of overseas commercial kidney transplantation: an Australian perspective

Med J Aust. 2005 Mar 7;182(5):224-7.

Abstract

Lack of donors has led to a worldwide increase in commercial kidney transplantation programs where recipients acquire kidneys either from executed prisoners or live non-related donors. Commercial transplantation is prohibited by legislation in Australia. Our centres have had 16 patients who have travelled overseas to receive a commercial kidney transplant; five have subsequently died. As has been found previously, patients who received commercial transplants were more likely to develop infections such as HIV, hepatitis B virus, cytomegalovirus and fungal infections. Previous reports have found that patient and graft survival were comparable to local results, whereas we found that patient and graft survival were worse than transplantation within Australia. Patients considering the option of overseas commercial donation should be advised that heightened risks to life and graft survival exist.

MeSH terms

  • Adult
  • Aged
  • Aspergillosis / etiology
  • Australia
  • Cytomegalovirus Infections / etiology
  • Female
  • Graft Rejection / etiology
  • Graft Survival
  • Hepatitis B / etiology
  • Humans
  • Internationality
  • Kidney Transplantation* / adverse effects
  • Living Donors
  • Male
  • Middle Aged
  • New South Wales
  • Postoperative Complications
  • Survival Rate
  • Tissue Donors*
  • Tissue and Organ Procurement*
  • Travel
  • Treatment Outcome